Ultra Market Research | United Kingdom Metoject PEN Market
United Kingdom Metoject PEN Market
Report ID : 984
Category : Therapeutic-Area,United-Kingdom(UK)
No Of Pages : 82
Published on: January 2025
Status: Published
Format :
Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
United Kingdom Metoject PEN Market Introduction United Kingdom Metoject PEN Market is the market for Metoject PEN, a prefilled autoinjector pen containing methotrexate, mainly used for the treatment of autoimmune diseases such as rheumatoid arthritis, psoriasis, and Crohn's disease. The growing prevalence of rheumatoid arthritis and other inflammatory conditions in the UK has greatly driven the demand for Metoject PEN. The market is shifting towards self-administrable treatment solutions, reducing dependency on healthcare facilities. As of 2024, the UK injection pen market, which includes products like Metoject PEN, generated a revenue of USD 1,387.9 million in 2024 and is expected to reach USD 2,146.1 million by 2030, growing at a CAGR of 7.5% from 2025 to 2030.. Increasing adoption of biologics and biosimilars, coupled with government support for cost-effective treatment options, is positively influencing the market. Furthermore, advancements in drug delivery systems are enhancing patient compliance, thus boosting the market.
Market Segmentation By Application • Rheumatoid Arthritis o Moderate RA o Severe RA o Juvenile Idiopathic Arthritis o Others • Psoriasis o Plaque Psoriasis o Psoriatic Arthritis o Others • Crohn’s Disease & Inflammatory Bowel Disease (IBD) o Mild Crohn’s Disease o Severe Crohn’s Disease • Other Autoimmune Diseases
By Distribution Channel • Hospital Pharmacies o Public Hospitals o Private Hospitals • Retail Pharmacies o Independent Pharmacies o Chain Pharmacies • Online Pharmacies
By End Users • Hospitals & Clinics • Specialty Centers • Homecare Settings • Others
Drivers United Kingdom Metoject PEN Market is driven by a growing prevalence of autoimmune diseases such as rheumatoid arthritis and psoriasis that are increasingly common among the ageing population. Awareness of healthcare, along with preference for convenient self-administration rather than traditional injections or infusions, is fuelling demand for Metoject PEN. Governments also are focusing on cost-effective health care measures like the reimbursement policy of the NHS, which will further fuel penetration in the market. Advances in autoinjectors with better precision in dosing and lessening side effects, biosimilars and biologics gaining ground, enhancing the affordability of methotrexate-based therapies, will have a positive growth impact.
Restraints Although the United Kingdom Metoject PEN Market is experiencing positive growth, it is challenged by strict regulatory requirements and periodic price fluctuations resulting from healthcare budget constraints. The safety issues related to methotrexate toxicity, such as hepatotoxicity and bone marrow suppression, affect patient compliance. Lack of awareness about methotrexate auto-injectors among newly diagnosed patients and the preference for alternative therapies will be a major limiting factor to market growth. Additionally, the competition from biosimilars and oral methotrexate formulations will hinder the adoption of Metoject PEN.
Opportunities United Kingdom Metoject PEN Market offers significant growth opportunities as the adoption of home-based self-administration solutions is increasing. The aging population and growing autoimmune diseases-related cases further project an expanding target market. Product demand would be enhanced through collabo rations with hospitals and other healthcare organizations to make the product accessible and more adaptive for awareness campaigns among patients. Online pharmacy services and telemedicine solutions would expand access to Metoject PEN from the patient's end. Research on the next-generation autoinjectors that are considered safer will bring in new markets for expansion.
Trends Demand for the UK Metoject PEN Market is increasing because of the preference of patients to administer themselves, which reduces the workload of healthcare providers. E-commerce and online sales of pharmacies have further facilitated easy access to prescription-based injectable drugs. Pharmaceutical companies are also investing in R&D to develop more user-friendly and less painful injection systems. The smart autoinjectors with digital tracking features are emerging, enabling healthcare providers to monitor patient adherence remotely. Another trend is the increasing use of biosimilars and generic methotrexate formulations as cost-effective alternatives to branded Metoject PEN.
The increasing prevalence of autoimmune diseases and patient preference for self-administration are key factors driving market growth.
The market is expected to reach USD 2,146.1 million by 2030, growing at a CAGR of 7.5% from 2025 to 2030.
Key market players include Medac Pharma, Accord Healthcare, Pfizer, Novartis, Teva Pharmaceuticals, and Amgen.
Stringent regulatory requirements, methotrexate toxicity concerns, and competition from biosimilars are major challenges.
The 15 mg and 20 mg dosage strengths are widely preferred for rheumatoid arthritis treatment.
1. Introduction 1.1 Report Description 1.2 Research Methodology 1.2.1 Data Mining 1.2.2 Market Modeling and Forecasting 1.2.3 Data Validation 1.2.4 Industry Analysis
2. Market Dashboard
3. Market Overview 3.1 Market Definition and Scope 3.2 Market Segmentation 3.2.1 By Product Type • Disposable Injection Pens • Reusable Injection Pens 3.2.2 By Application • Rheumatoid Arthritis • Psoriasis • Other Autoimmune Diseases 3.2.3 By Distribution Channel • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies 3.2.4 By End-User • Hospitals and Clinics • Homecare Settings • Specialty Clinics 3.3 Market Dynamics 3.3.1 Drivers 3.3.2 Restraints 3.3.3 Opportunities 3.3.4 Challenges
4. United Kingdom Metoject PEN Market by Product Type 4.1 Introduction 4.2 Market Size and Growth Rate by Product Type (2024-2030) 4.2.1 Disposable Injection Pens 4.2.2 Reusable Injection Pens
5. United Kingdom Metoject PEN Market by Application 5.1 Introduction 5.2 Market Size and Growth Rate by Application (2024-2030) 5.2.1 Rheumatoid Arthritis • Adult Patients • Juvenile Patients 5.2.2 Psoriasis • Plaque Psoriasis • Psoriatic Arthritis 5.2.3 Other Autoimmune Diseases • Crohn’s Disease • Ulcerative Colitis
6. United Kingdom Metoject PEN Market by Distribution Channel 6.1 Introduction 6.2 Market Size and Growth Rate by Distribution Channel (2024-2030) 6.2.1 Hospital Pharmacies • Public Hospitals • Private Hospitals 6.2.2 Retail Pharmacies • Chain Pharmacies • Independent Pharmacies 6.2.3 Online Pharmacies
7. United Kingdom Metoject PEN Market by End-User 7.1 Introduction 7.2 Market Size and Growth Rate by End-User (2024-2030) 7.2.1 Hospitals and Clinics • Rheumatology Departments • Dermatology Departments 7.2.2 Homecare Settings 7.2.3 Specialty Clinics
8. Competitive Landscape 8.1 Company Profiles 8.1.1 Medac GmbH (Germany) • Business Overview • Product Portfolio • Strategic Developments • Financial Overview 8.1.2 Pfizer Inc. (United States) 8.1.3 Teva Pharmaceutical Industries Ltd. (Israel) 8.1.4 Mylan N.V. (United States) 8.1.5 Sandoz International GmbH (Germany) 8.1.6 Sanofi S.A. (France) 8.1.7 Eli Lilly and Company (United States) 8.1.8 Novo Nordisk A/S (Denmark) 8.1.9 Biogen Inc. (United States) 8.1.10 Amgen Inc. (United States) 8.1.11 AbbVie Inc. (United States) 8.1.12 F. Hoffmann-La Roche AG (Switzerland) 8.1.13 UCB S.A. (Belgium) 8.1.14 Bristol-Myers Squibb Company (United States) 8.1.15 GlaxoSmithKline plc (United Kingdom)
9. Conclusion and Recommendations
10. Appendix 10.1 List of Tables Table 1: Market Size of United Kingdom Metoject PEN Market by Product Type (2024-2030) [in USD Million]
Table 2: Market Size of United Kingdom Metoject PEN Market by Application (2024-2030) [in USD Million]
Table 3: Market Size by Distribution Channel (2024-2030) [in USD Million]
Table 4: Market Share by End-User (2024-2030) [in USD Million] Table 5: Market Share of Leading Companies (2024-2030) [in %]
Table 6: Key Takeaways and Strategic Recommendations for Market Players
10.2 List of Figures
Figure 1: Market Share by Product Type (2024-2030) [Pie Chart]
Figure 2: Market Share by Application (2024-2030) [Bar Chart]
Figure 3: Growth Rate by Distribution Channel (2024-2030) [Line Graph]
Figure 4: Percentage Distribution of End-Users (2024-2030) [Pie Chart]
Figure 5: Competitive Positioning of Major Players [Bubble Chart]
Research Methodology
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done, and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of United Kingdom market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of United Kingdom Metoject PEN Market and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of United Kingdom Metoject PEN Market for the past year and forecasts for the next six years. United Kingdom Metoject PEN Market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different United Kingdom Metoject PEN Market categories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for United Kingdom Metoject PEN Market from different application industries in different regions.
Market Segmentation By Application • Rheumatoid Arthritis o Moderate RA o Severe RA o Juvenile Idiopathic Arthritis o Others • Psoriasis o Plaque Psoriasis o Psoriatic Arthritis o Others • Crohn’s Disease & Inflammatory Bowel Disease (IBD) o Mild Crohn’s Disease o Severe Crohn’s Disease • Other Autoimmune Diseases
By Distribution Channel • Hospital Pharmacies o Public Hospitals o Private Hospitals • Retail Pharmacies o Independent Pharmacies o Chain Pharmacies • Online Pharmacies
By End Users • Hospitals & Clinics • Specialty Centers • Homecare Settings • Others
